← FDA DRUG APPROVALS
FDA ANDA · ANDA201402
CLOBETASOL PROPIONATE EMOLLIENT FORMULATION
clobetasol propionate
Sponsor: PADAGIS ISRAEL
APPLICATION
ANDA201402
TYPE
ANDA
ORIGINAL APPROVAL
2012-08-14
LATEST ACTION
2019-09-06
ROUTE
TOPICAL
DOSAGE FORM
AEROSOL, FOAM
MARKETING STATUS
Prescription
Products
CLOBETASOL PROPIONATEPrescription
CLOBETASOL PROPIONATE 0.05% · AEROSOL, FOAM · TOPICAL
Approval history
2019-09-06Labeling · Supplement 2 · standardAP
2019-09-06Labeling · Supplement 13 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.